Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Delivery and monitoring of inhaled nitric oxide.

Literature DB >> 8857443

Delivery and monitoring of inhaled nitric oxide.

Abstract

Inhaled nitric oxide is rapidly gaining popularity as a selective pulmonary vasodilator in patients with acute lung injury and pulmonary hypertension. The development of nitric oxide as a drug has bypassed the usual regulatory and commercial processes, and as a result clinicians have devised a wide range of delivery and monitoring systems. This review describes these systems, and discusses their advantages, disadvantages and safety. The monitoring of nitric oxide metabolites is also discussed.

Entities: Chemical Disease Species

Mesh：

Substances：
Nitric Oxide

Year: 1996 PMID： 8857443 DOI： 10.1007/bf01728336

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

52 in total

1. Safety guidelines for use of nitric oxide.

Authors: L Foubert; B Fleming; R Latimer; M Jonas; A Oduro; C Borland; T Higenbottam
Journal: Lancet Date: 1992-06-27 Impact factor: 79.321

Review 2. St Cyres lecture. Endothelium in control.

Authors: A H Henderson
Journal: Br Heart J Date: 1991-03

3. Effect of nitric oxide on the oxygen transport of human erythrocytes.

Authors: K Kon; N Maeda; T Shiga
Journal: J Toxicol Environ Health Date: 1977-05

4. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

Authors: H Gerlach; R Rossaint; D Pappert; K J Falke
Journal: Eur J Clin Invest Date: 1993-08 Impact factor: 4.686

5. Down-regulation of endogenous nitric oxide production after prolonged administration.

Authors: A J Petros
Journal: Lancet Date: 1994-07-16 Impact factor: 79.321

6. Bleeding time prolongation and NO inhalation.

Authors: M Högman; C Frostell; H Arnberg; G Hedenstierna
Journal: Lancet Date: 1993-06-26 Impact factor: 79.321

7. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide.

Authors: C D Borland; T W Higenbottam
Journal: Eur Respir J Date: 1989-01 Impact factor: 16.671

8. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer.

Authors: H Guenard; N Varene; P Vaida
Journal: Respir Physiol Date: 1987-10

9. An appraisal of techniques for administration of gaseous nitric oxide.

Authors: J Tibballs; M Hochmann; B Carter; A Osborne
Journal: Anaesth Intensive Care Date: 1993-12 Impact factor: 1.669

10. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension.

Authors: C Girard; J J Lehot; J C Pannetier; S Filley; P Ffrench; S Estanove
Journal: Anesthesiology Date: 1992-11 Impact factor: 7.892

7 in total

1. Inhaled nitric oxide fraction is influenced by both the site and the mode of administration.

Authors: E Sieffert; L Ducros; M R Losser; D M Payen
Journal: J Clin Monit Comput Date: 1999-12 Impact factor: 2.502

2. A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine.

Authors: S Beloucif; D Payen
Journal: Intensive Care Med Date: 1998-08 Impact factor: 17.440

3. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS.

Authors: B H Cuthbertson; P Dellinger; O J Dyar; T E Evans; T Higenbottam; R Latimer; D Payen; S A Stott; N R Webster; J D Young
Journal: Intensive Care Med Date: 1997-12 Impact factor: 17.440